We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

12 hedge funds and large institutions have $5.11M invested in Arcadia Biosciences in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.02% more ownership

Funds ownership: 0% → 0.02% (+0.02%)

25% less funds holding

Funds holding: 16 → 12 (-4)

56% less capital invested

Capital invested by funds: $11.6M → $5.11M (-$6.48M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$65.9K
2
TRCT
Tower Research Capital (TRC)
New York
+$15.9K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.27K
4
BFA
BlackRock Fund Advisors
California
+$1.14K

Top Sellers

Rank Fund Capital Flow
1
WRF
Waddell & Reed Financial
Kansas
-$720K
2
Citadel Advisors
Citadel Advisors
Florida
-$19K
3
Goldman Sachs
Goldman Sachs
New York
-$10.2K
4
Bank of America
Bank of America
North Carolina
-$9K
5
UBS Group
UBS Group
Switzerland
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$4.47M -$720K -634 -9%
LRPA
2
L. Roy Papp & Associates
Arizona
$339K – – –
BCM
3
Bridgeway Capital Management
Texas
$69K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$62K +$2.27K +2 +2%
Norges Bank
5
Norges Bank
Norway
$43K – – –
VKH
6
Virtu KCG Holdings
New York
$43K +$65.9K +58 New
BFA
7
BlackRock Fund Advisors
California
$33K +$1.14K +1 +2%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$24K – – –
Goldman Sachs
9
Goldman Sachs
New York
$15K -$10.2K -9 -31%
TRCT
10
Tower Research Capital (TRC)
New York
$15K +$15.9K +14 +233%
BIM
11
BlackRock Investment Management
Delaware
$2K – – –
Wells Fargo
12
Wells Fargo
California
$2K – – –
Citadel Advisors
13
Citadel Advisors
Florida
– -$19K -13 Closed
Bank of America
14
Bank of America
North Carolina
– -$9K -6 Closed
UBS Group
15
UBS Group
Switzerland
– -$7K -5 Closed
FMA
16
FNY Managed Accounts
New York
– -$4.09K -3 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– -$1K -1 Closed

RKDA Hedge Fund Activity: Q4 2016 in Review

12 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2016, worth a combined $5.11M — down 56% from $11.6M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of RKDA and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $65.9K. The largest seller was Waddell & Reed Financial, cutting an estimated $720K.

  • 12 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2016, down from 16 in Q3 2016.
  • Funds reported $5.11M of Arcadia Biosciences stock for Q4 2016, down 56% quarter-over-quarter.
  • 1 fund opened new Arcadia Biosciences positions in Q4 2016 and 5 closed out, a net change of -4 holders.
  • The largest Arcadia Biosciences buyer in Q4 2016 was Virtu KCG Holdings, an estimated $65.9K added.
  • The largest Arcadia Biosciences seller in Q4 2016 was Waddell & Reed Financial, an estimated $720K sold.

Based on aggregated 13F filings for Q4 2016.